Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial
Authors
Marcy, OlivierLaureillard, Didier
Madec, Yoann
Chan, Sarin
Mayaud, Charles
Borand, Laurence
Prak, Narom
Kim, Chindamony
Lak, Kim Khemarin
Hak, Chanroeurn
Dim, Bunnet
Sok, Thim
Delfraissy, Jean-François
Goldfeld, Anne E
Blanc, François-Xavier
Issue Date
2014-08
Metadata
Show full item recordJournal
Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of AmericaAbstract
Shortening the interval between antituberculosis treatment onset and initiation of antiretroviral therapy (ART) reduces mortality in severely immunocompromised human immunodeficiency virus (HIV)-infected patients with tuberculosis. A better understanding of causes and determinants of death may lead to new strategies to further enhance survival.Publisher
Oxford University PressPubMed ID
24759827Language
enISSN
1537-6591ae974a485f413a2113503eed53cd6c53
10.1093/cid/ciu283
Scopus Count
Collections
Related articles
- Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.
- Authors: Laureillard D, Marcy O, Madec Y, Chea S, Chan S, Borand L, Fernandez M, Prak N, Kim C, Dim B, Nerrienet E, Sok T, Delfraissy JF, Goldfeld AE, Blanc FX, CAMELIA (ANRS 1295 – CIPRA KH001) Study Team.
- Issue date: 2013 Oct 23
- Clinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors.
- Authors: Pepper DJ, Marais S, Wilkinson RJ, Bhaijee F, Maartens G, McIlleron H, De Azevedo V, Cox H, McDermid C, Sokhela S, Patel J, Meintjes G
- Issue date: 2010 Mar 30
- Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study.
- Authors: Marcy O, Tejiokem M, Msellati P, Truong Huu K, Do Chau V, Tran Ngoc D, Nacro B, Ateba-Ndongo F, Tetang-Ndiang S, Ung V, Dim B, Neou L, Berteloot L, Borand L, Delacourt C, Blanche S, ANRS 12229 PAANTHER 01 Study Group.
- Issue date: 2018 Feb
- Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.
- Authors: Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, Madec Y, Marcy O, Chan S, Prak N, Kim C, Lak KK, Hak C, Dim B, Sin CI, Sun S, Guillard B, Sar B, Vong S, Fernandez M, Fox L, Delfraissy JF, Goldfeld AE, CAMELIA (ANRS 1295–CIPRA KH001) Study Team.
- Issue date: 2011 Oct 20
- Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults.
- Authors: Blanc FX, Badje AD, Bonnet M, Gabillard D, Messou E, Muzoora C, Samreth S, Nguyen BD, Borand L, Domergue A, Rapoud D, Natukunda N, Thai S, Juchet S, Eholié SP, Lawn SD, Domoua SK, Anglaret X, Laureillard D, STATIS ANRS 12290 Trial Team.
- Issue date: 2020 Jun 18